1 other would like to attend.
Register Now
Friday, April 19, 2024 7 AM
-
Saturday, April 20, 2024
4 PM
America/Chicago
Add to Calendar
320 N Dearborn St Chicago, IL 60654 United States
Event info
OVERVIEW
The 21st International Ultmann Chicago Lymphoma Symposium (IUCLS) is a continuation of an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of national practicing oncologists, advanced nurse practitioners and physician assistants, nurses, residents, fellows, and the Chicago academic community that includes five academic centers. This year’s program will be offered live on April 19-20, 2024, and represents the 21st IUCLS.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes a combination of expert presentations, interactive case discussions, poster and abstract presentations, and an opportunity for question-and-answer debates. Additionally, the entire conference will be certified for nursing continuing education credits.
The goal of this educational activity is to facilitate a forum for physicians, nurses, researchers, and other healthcare professionals to discuss biologic, diagnostic, and therapeutic aspects of Hodgkin and non-Hodgkin lymphoma.
IUCLS will gather both domestic and international clinicians and researchers specializing in the treatment of patients with lymphoma.
This event gives opportunities for providers to explore vital information on clinical updates and research in order to ensure they are using the latest treatment options in their practice.
Learn more at the symposium website!
TARGET AUDIENCE
This activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and other healthcare professionals interested in the treatment and diagnosis of lymphoma.
LEARNING OBJECTIVES
At the conclusion of this educational activity, participants will be able to:
-
Evaluate the latest treatment strategies for patients with indolent and aggressive forms of B-cell non-Hodgkin lymphoma, such as follicular lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma;
-
Assess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma;
-
Compare and contrast the various patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL;
-
Discuss approaches to the care of patients with rare lymphoma subtypes, including Burkitt lymphoma and peripheral T-cell lymphoma;
-
Develop strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For more information please visit the official event page.
1 other would like to attend.
Register Now
Comments 0
Login to view comments.
Click here to Login